Работы, цитирующие эту работу

Работ: 4

Работа: Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

1. Targeting VCAM-1 with chimeric antigen receptor and regulatory T cell for abdominal aortic aneurysm treatment

   Qingwei Gang, Yu Lun, Xiaoxu Zhang +10

   СтатьяCAR-T cell therapy researchCommunications Biology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2025.article.000953

2. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   СтатьяCAR-T cell therapy researchHeliyon2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.102962

3. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

   Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

   Обзорная статьяCAR-T cell therapy researchCritical Reviews in Oncology/Hematology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000011

4. Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities

   Фарида Муиновна Хамидова, Zarina Babaeva, Khasan Jafarov +6

   СтатьяImmunotherapy and Immune ResponsesClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.025804